• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest
with regard to the quality, safety, and efficacy of care, and only after the patient has been
informed and has provided consent.• Country-specific health regulations, indications by
governmental drug regulatory agencies, and the ethical rules to which health professionals
are subject, where applicable.

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC
Guidelines may be translated or reproduced in any form without written permission from the
ESC. Permission can be obtained upon submission of a written request to Oxford University
Press, the publisher of the European Heart Journal and the party authorized to handle such
permissions on behalf of the ESC (journals. permissions@ oup. com). Disclaimer. The ESC …